92869 ⎘
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
O-TERT-BUTYL-L-SERYL-O-TERT-BUTYL-L-SERYL-GLYCINE AND PREPARATION METHOD THEREOF
#2MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
#3M24B AMINOPEPTIDASE INHIBITORS FOR CARD8 INFLAMMASOME ACTIVATION
#4METHOD OF SYNTHESIS OF AN IONIZABLE CATIONIC LIPID
#5NOVEL AMINO ACID DERIVATIVES
#6MULTIFUNCTIONAL LINKER COMPOUNDS
#7Solid Support
#8CATIONIC LIPID ANALOGUES, COMPOSITIONS AND USES THEREOF
#9DIPEPTIDOMIMETICS AS INHIBITORS OF HUMAN IMMUNOPROTEASOMES
#10NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME
#11Derivative of aspartic acid and use thereof in treatment of metabolic diseases such as hepatic fibrosis and non-alcoholic hepatitis
#12MIXED AMIDE ESTER CONTAINING LIPIDS FOR USE IN LIPID NANOPARTICLES
#13AGENTS FOR IMPROVED DELIVERY OF NUCLEIC ACIDS TO EUKARYOTIC CELLS
#14PRODRUGS OF ITACONATE AND METHYL ITACONATE
#15IONIZABLE CATIONIC LIPIDS FOR RNA DELIVERY
#16Compositions and Methods For Reducing Immune Intolerance and Treating Autoimmune Disorders
#17AUTOMATED SYNTHESIS OF POLYMERIC DRUGS
#18UNNATURAL AMINO ACID, AND USE THEREOF, RECOMBINANT PROTEIN CONTAINING SAME, AND RECOMBINANT PROTEIN CONJUGATE
#19APPLICATION OF ASPARTIC ACID DERIVATIVE IN PREPARING ANIMAL FEED ADDITIVE
#20PROCESSES FOR THE PREPARATION OF (S)-TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE
#21MODULATORS OF SORTILIN ACTIVITY
#22Substituted Cyclohexanecarboxamides, Their Preparation and Their Therapeutic Application
#23LOCAL ANESTHETICS WITH SELECTIVE-SENSORY NERVE BLOCKADE
#24COMPOUNDS AND COMPOSITIONS FOR DRUG DELIVERY
#25HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF
#26HYBRID CARRIERS FOR NUCLEIC ACID CARGO
#27LIPID NANOPARTICLE COMPOSITION
#28Processes for the preparation of ()-tert-butyl 4,5-diamino-5-oxopentanoate
#29AMINO ACID DERIVATIVES AND THEIR USE AS FLAVOR MODIFIERS
#30AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF
#31Lipid compound as well as lipid carrier, nucleic acid lipid nanoparticle composition and pharmaceutical preparation containing same
#32PRODRUGS OF ITACONATE AND METHYL ITACONATE
#33MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
#34ZWITTERIONIC CROSSLINKERS, HYDROGELS COMPRISING ZWITTERIONIC CROSSLINKERS, AND METHODS FOR MAKING AND USING
#35Vegetable oil-based material as a substitute for carnauba wax
#36Lipid nanoparticle composition
#37Dipeptidomimetics as inhibitors of human immunoproteasomes
#38Compositions and methods relating to salts of specialized pro-resolving mediators
#39Application of aspartic acid derivative in preparing animal feed additive
#40Solid support
#41Agents for improved delivery of nucleic acids to eukaryotic cells
#42Compositions and methods relating to salts of specialized pro-resolving mediators
#43Modulators of Sestrin-GATOR2 interaction and uses thereof
#44Vegetable oil-based material as a substitute for carnauba wax
#45Method of synthesis of an ionizable cationic lipid
#46Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#47Processes for the preparation of (S)-tert-butyl 4,5- diamino-5-oxopentanoate
#48Derivatives of sobetirome
#49Hybrid carriers for nucleic acid cargo
#50Compositions and methods relating to salts of specialized pro-resolving mediators
#51Method for producing amide compound
#52Modulators of Sestrin-GATOR2 interaction and uses thereof
#53Agents for improved delivery of nucleic acids to eukaryotic cells
#5418F labeled amino acids, derivatives thereof and method of making same
#55PENDANT AMINES AND DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
#56Autophagy activation-induced compound for improving skin inflammation for aging
#57Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof
#58Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate
#59Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#60Modulators of sestrin-GATOR2 interaction and uses thereof
#61Vegetable oil-based material as a substitute for carnauba wax
#62FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON'S TYROSINE KINASE
#63Dipeptidomimetics as inhibitors of human immunoproteasomes
#64Method of synthesis of an ionizable cationic lipid
#65Ionizable cationic lipid for RNA delivery
#66Pendant amines and derivatives as inhibitors of leukotriene A4 hydrolase
#67Compositions and methods relating to salts of specialized pro-resolving mediators
#68Compositions for prevention/prophylactic treatment of poison ivy dermatitis
#69Agents for improved delivery of nucleic acids to eukaryotic cells
#70NOVEL COMPOUNDS
#71Short chain PEGylation of amino acid monomers glutamine, lysine and peptides formed thereby
#72Ionizable cationic lipid for RNA delivery
#73Substituted biaryl alkyl amides
#74Compositions and methods for the treatment of hyperglycemia and metabolic syndrome
#75Lipid particles with asymmetric cationic lipids for RNA delivery
#76Derivatives of sobetirome
#77Agents for improved delivery of nucleic acids to eukaryotic cells
#78Synthesis of new anionic surfactants and their use as collectors in froth flotation of non-sulphidic ores
#79Compositions and methods relating to ionic salts of peptides
#80DISPERSANTS
#81Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient
#82Asymmetric ionizable cationic lipid for RNA delivery
#83Ionizable cationic lipid for RNA delivery
#84Labeled molecular imaging agents and methods of use
#85Compositions for prevention/prophylactic treatment of poison ivy dermatitis
#86Method for producing cereulide and derivative thereof, intermediate for production of cereulide, and cereulide derivative
#87Ionizable cationic lipid for RNA delivery
#88Basic amino acid derivative that demonstrates a gelling ability in a water system
#89Substituted biaryl alkyl amides
#90Small molecule inhibitors of AGBL2
#91Compositions for prevention/prophylactic treatment of poison ivy dermatitis
#92Drug-ligand conjugates, synthesis thereof, and intermediates thereto
#93Labeling agent and methods for simultaneous sequencing and quantification of multiple peptides and proteins using the same
#94Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
#95DRUG-LIGAND CONJUGATES, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO
#96Substituted biaryl alkyl amides
#97N-acyl amino acid derivatives for treating skin conditions such as cellulite
#984-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES
#99Conjugates for treating neurodegenerative diseases and disorders
#100Inhibition of sweat malodor
#101Aflatoxin production inhibitor and method for controlling aflatoxin contamination using the same
#102Glycine compound
#103Methods of Treatment Using a Prodrug of an Excitatory Amino Acid
#104Antagonists of the Magnesium Binding Defect as Therapeutic Agents and Methods for Treatment of Abnormal Physiological States
#105Novel Therapeutic Compounds
#1062-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
#107Class of cationic lipids for transporting active agents into cells
#108Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#109Methods of treatment using a prodrug of an excitatory amino acid
#110Compositions for prevention/prophylactic treatment of poison ivy dermatitis
#111Conjugates for treating neurodegenerative diseases and disorders
#112Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#113Branched water-soluble polymers and their conjugates
#114NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES
#115Agents for magnetic imaging method
#116Reagent for introduction of protein or gene
#1172-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
#118Amphiphilic molecule, molecular assembly comprising the amphiphilic molecule, and use of the molecular assembly
#119LYSINE RIBOSWITCHES, STRUCTURE-BASED COMPOUND DESIGN WITH LYSINE RIBOSWITCHES, AND METHODS AND COMPOSITIONS FOR USE OF AND WITH LYSINE RIBOSWITCHES
#120LUMINESCENT METAL COMPLEXES FOR MONITORING RENAL FUNCTION
#121Methods of treatment using a prodrug of an excitatory amino acid
#122Antagonist of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#123Compounds and compositions for delivering active agents
#124Methods of treating using conjugates transported by a PEPT2 transporter
#125POLYMORPHIC AND AMORPHOUS FORMS OF LACOSAMIDE AND AMORPHOUS COMPOSITIONS
#126AMINO ACID DERIVED PRODRUGS OF PROPOFOL, COMPOSITIONS AND USES THEREOF
#127PRODUCTION METHOD OF OPTICALLY ACTIVE PIPERAZINE COMPOUND
#1284-dimethylaminobutyric acid derivatives
#129Aminodicarboxylic acid derivatives having pharmaceutical properties
#130NOVEL ACYL GROUP-CONTAINING COMPOSITION
#131Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#132Prodrugs of propofol, compositions and uses thereof
#133Luminescent metal complexes for monitoring renal function
#134Compounds
#135COMPOUNDS FOR SUSTAINED RELEASE OF ORALLY DELIVERED DRUGS
#136Mitotic kinesin inhibitors
#137Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
#138Prodrugs of excitatory amino acids
#1392-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
#140β-Benzyloxyaspartic acid derivatives having two substituents on their benzene rings
#141Inhibitors for GlyT-1
#142Ester-linked gemini surfactant compounds for use in gene therapy
#143Multivalent chelators containing a scaffold structure for modifying and organizing of target molecules
#144Inhibition of sweat malodor
#145Isopeptide Gap Junction Modulators
#146Antagonist of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#147Diaminopropionic acid derivatives
#148Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
#149Nitrosated glutamic acid compounds, compositions and methods of use
#150Branched water-soluble polymers and their conjugates
#151Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
#152Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
#153Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#154Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
#155Compounds and compositions for delivering active agents
#156Bile-acid conjugates providing for sustained systemic concentration of drugs
#157Amino acid derived prodrugs of propofol, compositions and uses thereof
#158Aminodicarboxylic acid derivatives having pharmaceutical properties
#159Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#160Cationic liposomes for gene transfer
#161Prodrugs of propofol, compositions and uses thereof
#162Bile-acid conjugates for providing sustained systemic concentrations of drugs
#163Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
#164Composition containing acyl group
#165Prodrugs of excitatory amino acids
#166Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
#167Method for preparing β-alaninamides
#168Compounds and compositions for delivering active agents
#169Agents for magnetic imaging method
#1702-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
#1712-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
#1722-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
#173Bile-acid conjugates providing for sustained systemic concentration of drugs
#174Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
#175Diaminopropionic acid derivatives
#176Prodrugs of amino acids with affinity for the α2δ-protein
#177Compounds for sustained release of orally delivered drugs
#178Amino acid derived prodrugs of propofol, compositions and uses thereof